PolyNovo Investor Relations Material
Latest events
H1 2025
PolyNovo
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PolyNovo Limited
Access all reports
PolyNovo Limited is an Australian medical device company specializing in the development and manufacturing of advanced wound care solutions using its proprietary NovoSorb biodegradable polymer technology. The company's flagship product, NovoSorb Biodegradable Temporizing Matrix (BTM), is designed to support dermal regeneration in patients who have suffered tissue loss due to burns, trauma, or surgical procedures. NovoSorb BTM is utilized in various medical applications, including the treatment of complex wounds, chronic ulcers, and surgical wounds. Additionally, PolyNovo is expanding its product portfolio to include applications in hernia repair and other reconstructive surgeries. PolyNovo Limited is headquartered in Port Melbourne, Victoria, Australia, and its shares are listed on the Australian Securities Exchange.
Key slides for PolyNovo Limited
H1 2025
PolyNovo Limited
H1 2025
PolyNovo Limited
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PNV
Country
🇦🇺 Australia